Minimize impact of testing: Sterility and bioburden supplementary survey

This member only survey was intended to gather information for Minimize Impact on Batch Yield sub-team on sterility and bioburden testing during batch manufacture/release testing of gene therapy products within BioPhorum C&GT member companies. The results will help shape the work program of the sub-team going forward.

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.